THE ANNEXIN A2 PATHWAY IN PROLIFERATIVE VITREORETINOPATHY: A NEW THERAPEUTIC TARGET

$1,192,997FY2021Defense Health AgencyDOD

Weill Medical College Of Cornell University

Investigators

THE ANNEXIN A2 PATHWAY IN PROLIFERATIVE VITREORETINOPATHY: A NEW THERAPEUTIC TARGET · GrantIndex